KR970705395A - 2,3-디하이드로-1-(2,2,2-트리플루오로에틸)-2-옥소-5-페닐-1H-1,4-벤조디아제핀(2,3-Dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepines) - Google Patents
2,3-디하이드로-1-(2,2,2-트리플루오로에틸)-2-옥소-5-페닐-1H-1,4-벤조디아제핀(2,3-Dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepines) Download PDFInfo
- Publication number
- KR970705395A KR970705395A KR1019970701009A KR19970701009A KR970705395A KR 970705395 A KR970705395 A KR 970705395A KR 1019970701009 A KR1019970701009 A KR 1019970701009A KR 19970701009 A KR19970701009 A KR 19970701009A KR 970705395 A KR970705395 A KR 970705395A
- Authority
- KR
- South Korea
- Prior art keywords
- dihydro
- diazepin
- benzo
- acetamide
- trifluoroethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
본 발명은 화학식 (1)의 화합물, 라세미체, 에난티오머의 혼합물, 개별 디아스테레오머, 개별 에난티오머 또는 모든 이성질체 형태 및 약제학적으로 허용되는 이의 염, 수화물 또는 결정 형태에 관한 것이다.
상기 화합식 (1)에서 X와 Y는 독립적으로 수소, 클로로, 플루오로, 브로모, 요오드 또는 트리플루오로메틸이고, n은 0,1 또는 2이며, R은 수소, 플루오로, 클로로, 브로모, 요오도, 트리플루오로메틸, 메틸 또는 메톡시이다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (14)
- 항부정맥제인 화학식(1)의 화합물, 라세미체, 에난티오머의 혼합물, 개별 디아스테레오머, 개별 에난티오머 또는 모든 이성질체 형태 및 약제학적으로 허용되는 이의 염, 수화물 또는 결정 형태.상기 화합식(1)에서 X와 Y는 독립적으로 수소, 클로로, 플루오로, 브로모, 요오드 또는 트리플루오로메틸이고, n은 0,1 또는 2이며, R은 수소, 플루오로, 클로로, 브로모, 요오도, 트리플루오로메틸, 메틸 또는 메톡시이다.
- 제1항에 있어서, 다음 화합물들로 이루어진 그룹으로부터 선택되는 화합물. (-)-2-[2,4-비스(트리플루오로메틸)페닐]-N(3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조[e][1,4]디아제핀-3-일]아세트아미드.(2)(+)-3,5-디클로로-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]벤즈아미드(-)-3,4-디클로로페닐-1-일-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드.(-)-2-(3,5-디클로로페닐)-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,3-사이클로헥실-N-[2,3-디하이드로-5-(2-플루오로페닐)-2-옥소-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]프로피온아미드.3,4-디클로로-N-[2,3-디하이드로-5-(2-플루오로페닐)-2-옥소-1-(2,2,2-트리플루오로페닐)-1H-벤조-[e][1,4]디아제핀-3-일]벤즈아미드,(-)-2-[3,5-비스(트리플루오로메틸)페닐]-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,(-)-2-(4-트리플루오로메틸페닐)-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,(-)-2-(3-트리플루오로메틸페닐)-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,(-)-2-(2-트리플루오로메틸페닐)-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,(-)-2-(2,4-디클로로)-N-[3R-2,3-디하이드로-1-(2,2,2-트리플루오로에틸)-2-옥소-5-페닐-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,(-)-2-(2,3-클로로페닐)-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,(-)-2-(4-클로로페닐)-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,(+)-2-(3,5-디클로로페닐)-N-[2,3-디하이드로-5-(4-플루오로페닐)-2-옥소-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,(-)-2-(2,4-디클로로페닐)-N-[2,3-디하이드로-5-(4-플루오로페닐)-2-옥소-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,(+)-2-(3,5-비스(트리플루오로메틸)페닐)-N-[2,3-디하이드로-5-(4-플루오로페닐)-2-옥소-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,(-)-2-(2,4-디클로로페닐)-N-[2,3-디하이드로-5-(4-플루오로페닐)-2-옥소-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,(±)-2-(3,5-디클로로페닐)-N-[2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드 및2-(3,5-디클로로-4-메톡시페닐)-N-[2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드,
- 제1항에 있어서, 다음 화학식 (3)의 (+)-3,5-디클로로-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]벤즈아미드인 화합물.
- 제1항에 있어서, 다음 화학식 (4)의 (-)-2-(3,4-디클로로페닐)-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드인 화합물.
- 제1항에 있어서, 다음 화학식 (5)의 (-)-2-(3,5-디클로로페닐)-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드인 화합물.
- 제1항에 있어서, 다음 화학식 (2)의 (-)-2-[2,4-비스(트리플루오로메틸)페닐-N-[3R-2,3-디하이드로-2-옥소-5-페닐-1-(2,2,2-트리플루오로에틸)-1H-벤조-[e][1,4]디아제핀-3-일]아세트아미드인 화합물.
- 약제학적으로 형용되는 담체와 치료학적 유효량의 제1항의 화합물 또는 약제학으로 형용되는 이의 염, 결정형태 또는 수화물을 포함하는 약제학적 제형.
- 제7항에 있어서, 또 다른 항부정맥제 또는 다른 심혈관제를 추가를 포함하는 약제학적 제형.
- 부정맥의치료를 필요로 하는 환자에게 부정맥 치료 유효량의 제1항의 화합물을 투여함을 포함하여, 부정맥을 예방 또는 치료하는 방법.
- 제9항에 있어서, 또 다른 항부정맥제 또는 다른 심혈과제의 병행 투여를 포함하는 방법.
- 약제학적으로 허용되는 담체와 치료학적 유효량의 제6항의 화합물을 또는 약제학적으로 허용되는 이의 염,결정 형태, 또는 수화물을 포함하는 약제학적 제형.
- 제11항에 있어서, 또 다른 항부정맥제 또는 다른 심혈관제를 추가로 포함하는 약제학적 제형,
- 부정맥의 치료를 필요로 하는 환자에게 부정맥 치료 유효량의 제6항의 화합물을 투여함을 포함하여, 부정맥을 예방 또는 치료하는 방법.
- 제13항에 있어서, 또 다른 항부정맥제 또는 다른 심혈관제의 병행 투여를 포함하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29244794A | 1994-08-18 | 1994-08-18 | |
US08/292,447 | 1994-08-18 | ||
PCT/US1995/010500 WO1996005839A1 (en) | 1994-08-18 | 1995-08-17 | 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
Publications (1)
Publication Number | Publication Date |
---|---|
KR970705395A true KR970705395A (ko) | 1997-10-09 |
Family
ID=23124712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970701009A KR970705395A (ko) | 1994-08-18 | 1995-08-17 | 2,3-디하이드로-1-(2,2,2-트리플루오로에틸)-2-옥소-5-페닐-1H-1,4-벤조디아제핀(2,3-Dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepines) |
Country Status (24)
Country | Link |
---|---|
US (1) | US5658901A (ko) |
EP (1) | EP0776208B1 (ko) |
JP (1) | JPH10504570A (ko) |
KR (1) | KR970705395A (ko) |
CN (1) | CN1158568A (ko) |
AT (1) | ATE186463T1 (ko) |
AU (1) | AU692300B2 (ko) |
BG (1) | BG63032B1 (ko) |
BR (1) | BR9508608A (ko) |
CA (1) | CA2195974C (ko) |
CZ (1) | CZ285008B6 (ko) |
DE (1) | DE69513295T2 (ko) |
DK (1) | DK0776208T3 (ko) |
ES (1) | ES2139933T3 (ko) |
FI (1) | FI970668A0 (ko) |
GR (1) | GR3032592T3 (ko) |
HU (1) | HU220635B1 (ko) |
MX (1) | MX9701195A (ko) |
NO (1) | NO970731D0 (ko) |
NZ (1) | NZ291988A (ko) |
PL (1) | PL319104A1 (ko) |
RU (1) | RU2149161C1 (ko) |
SK (1) | SK282019B6 (ko) |
WO (1) | WO1996005839A1 (ko) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5631251A (en) * | 1995-06-07 | 1997-05-20 | Merck & Co., Inc. | 5-cyclopropyl-1,4 benzodiazepine-2-ones |
EP0907644A4 (en) * | 1996-06-28 | 2003-02-05 | Merck & Co Inc | PHARMACEUTICAL PREPARATION |
US5776930A (en) * | 1996-06-28 | 1998-07-07 | Merck & Company, Inc. | Pharmaceutical preparation |
US6683075B1 (en) | 1996-12-23 | 2004-01-27 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
US6635632B1 (en) * | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6262068B1 (en) | 1997-02-21 | 2001-07-17 | Bristol-Myers Squibb Company | Lactam derivatives as antiarrhythmic agents |
US6048877A (en) * | 1997-02-21 | 2000-04-11 | Bristol-Myers Squibb Company | Tetralone derivatives as antiarrhythmic agents |
AU6320998A (en) | 1997-02-21 | 1998-09-09 | Bristol-Myers Squibb Company | Benzoic acid derivatives and related compounds as antiarrhythmic agents |
US5817658A (en) * | 1997-03-14 | 1998-10-06 | Merck & Company, Inc. | Method for treating Meniere's disease |
GB2328942A (en) * | 1997-09-05 | 1999-03-10 | Merck & Co Inc | Side chain synthesis for an antiarrythmic compound |
US6214823B1 (en) | 1997-10-17 | 2001-04-10 | Merck & Co., Inc. | Benzodiazepine derivatives as antiarrhythmic agents |
ES2148057B1 (es) * | 1998-01-05 | 2001-05-16 | Univ Murcia | Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3 |
US6664250B2 (en) | 1998-01-20 | 2003-12-16 | Bristol-Myers Squibb Co. | Lactam derivatives as antiarrhythmic agents |
US6958330B1 (en) | 1998-06-22 | 2005-10-25 | Elan Pharmaceuticals, Inc. | Polycyclic α-amino-ε-caprolactams and related compounds |
US6509331B1 (en) | 1998-06-22 | 2003-01-21 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6569851B1 (en) | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6528505B1 (en) | 1998-06-22 | 2003-03-04 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6552013B1 (en) | 1998-06-22 | 2003-04-22 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6774125B2 (en) * | 1998-06-22 | 2004-08-10 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
JP4410328B2 (ja) * | 1998-12-14 | 2010-02-03 | 久光製薬株式会社 | オキソクアゼパムの製造方法 |
GB0221923D0 (en) * | 2002-09-20 | 2002-10-30 | Arrow Therapeutics Ltd | Chemical compounds |
US20050192265A1 (en) * | 2003-03-20 | 2005-09-01 | Thompson Richard C. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
CU20090172A6 (es) | 2009-10-09 | 2011-10-05 | Facultad De Quimica Universidad De La Habana | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT75373B (en) * | 1981-08-12 | 1986-06-18 | Agripat Sa | Process for the preparation of tinted contact lenses |
DE3134672A1 (de) * | 1981-09-02 | 1983-03-17 | Boehringer Ingelheim KG, 6507 Ingelheim | Heterocyclische verbindungen, ihre herstellung und verwendung |
US4473575A (en) * | 1982-07-19 | 1984-09-25 | Ciba-Geigy Corporation | 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids |
DE3373469D1 (en) * | 1982-09-30 | 1987-10-15 | Merck & Co Inc | 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents |
DK151808C (da) * | 1982-11-16 | 1988-06-20 | Ferrosan As | Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-oe1,4aa-benzodiazepinderivater |
US4537885A (en) * | 1983-02-10 | 1985-08-27 | Ciba Geigy Corporation | Certain benzazocinone and benzazoninone derivatives |
US4470988A (en) * | 1983-02-10 | 1984-09-11 | Ciba-Geigy Corporation | Benzazocinone and benzazoninone derivatives, and their pharmaceutical use |
IL74070A (en) * | 1984-01-19 | 1988-12-30 | Hoffmann La Roche | Imidazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them |
US4600534A (en) * | 1984-02-06 | 1986-07-15 | Ciba-Geigy Corporation | Process and intermediates for manufacture of 3-(5-amino-1-carboxypentylamino)-tetrahydro-1-benzazepin-2-one-1-acetic acid |
US5004741A (en) * | 1984-06-26 | 1991-04-02 | Merck & Co., Inc. | Methods of antagonizing CCK or gastrin with benzodiazepine analogs |
CA1332410C (en) * | 1984-06-26 | 1994-10-11 | Roger M. Freidinger | Benzodiazepine analogs |
US4820834A (en) * | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
US4692522A (en) * | 1985-04-01 | 1987-09-08 | Merck & Co., Inc. | Benzofused lactams useful as cholecystokinin antagonists |
US4847248A (en) * | 1986-12-23 | 1989-07-11 | Merck & Co., Inc. | 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists |
US4992437A (en) * | 1987-12-22 | 1991-02-12 | Yoshitomi Pharmaceutical Industries, Ltd. | Thienodiazepine compounds and their pharmaceutical use |
EP0322779A3 (en) * | 1987-12-29 | 1991-05-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzolactam compounds and pharmaceutical uses thereof |
US5166151A (en) * | 1988-03-25 | 1992-11-24 | Merck & Co., Inc. | 2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof |
US5324726A (en) * | 1989-12-18 | 1994-06-28 | Merck & Co., Inc. | Benzodiazepine analogs |
US5206234A (en) * | 1990-10-22 | 1993-04-27 | Merck & Co., Inc. | Benzolactam analogs as antagonists of cck |
US5220018A (en) * | 1991-04-10 | 1993-06-15 | Merck & Co., Inc. | Cholecystokinin antagonists |
CA2068355A1 (en) * | 1991-05-14 | 1992-11-15 | Mark S. Chambers | Benzodiazephine derivatives, compositions containing them and their use in therapy |
GB9116113D0 (en) * | 1991-07-25 | 1991-09-11 | Merck Sharp & Dohme | Therapeutic agents |
DE4125457A1 (de) * | 1991-08-01 | 1993-02-04 | Bayer Ag | Verfahren zur herstellung von n-substituierten lactamen |
ES2140396T3 (es) * | 1991-09-30 | 2000-03-01 | Yoshitomi Pharmaceutical | Compuesto de tienodiazepina y su uso. |
WO1993007131A1 (en) * | 1991-10-10 | 1993-04-15 | Merck Sharp & Dohme Limited | Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors |
WO1993008176A1 (en) * | 1991-10-24 | 1993-04-29 | Merck Sharp & Dohme Limited | Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors |
AU2759692A (en) * | 1991-10-24 | 1993-05-21 | Glaxo Group Limited | Benzodiazepine derivatives as antagonists of gastrin and/or cholecystokinin |
US5428031A (en) * | 1991-12-03 | 1995-06-27 | Merck & Co., Inc. | Methods of treating cardiac arrhythmia |
EP0549039B1 (en) * | 1991-12-20 | 1995-08-09 | MERCK SHARP & DOHME LTD. | 3-Phenylureido-1,4-Benzodiazepinones and their use as cholecystokinin or gastrin antagonists |
ZA93436B (en) * | 1992-01-24 | 1993-08-25 | Chugai Pharmaceutical Co Ltd | Benzopyran derivatives |
GB9203790D0 (en) * | 1992-02-21 | 1992-04-08 | Merck Sharp & Dohme | Therapeutic agents |
US5597915A (en) * | 1992-03-16 | 1997-01-28 | Merck Sharp & Dohme Ltd. | Benzodiazepine derivatives, compositions containing them and their use in therapy |
IT1254558B (it) * | 1992-03-26 | 1995-09-25 | Mini Ricerca Scient Tecnolog | Composti a base di 3,4-diaril-(5h)-furan-2-one ad attivita' fungicida 3 |
GB9209518D0 (en) * | 1992-05-01 | 1992-06-17 | Merck Sharp & Dohme | Therapeutic agents |
US5360802A (en) * | 1992-05-11 | 1994-11-01 | Merck Sharpe & Dohme Ltd. | Benzodiazepine derivatives, compositions containing them and their use in therapy |
GB9218412D0 (en) * | 1992-08-28 | 1992-10-14 | Merck Sharp & Dohme | Therapeutic agents |
US5438055A (en) * | 1993-11-22 | 1995-08-01 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
US5426185A (en) * | 1993-11-22 | 1995-06-20 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
US5428157A (en) * | 1993-11-22 | 1995-06-27 | Merck & Co., Inc. | 3-acylaminobenzodiazepines |
US5439906A (en) * | 1993-11-22 | 1995-08-08 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
US5441950A (en) * | 1994-06-09 | 1995-08-15 | G. D. Searle & Co. | Substituted dibenzoxazepine and dibenzthiazepine carbamate compounds, pharmaceutical compositions and methods of use |
-
1995
- 1995-08-17 EP EP95930197A patent/EP0776208B1/en not_active Expired - Lifetime
- 1995-08-17 DK DK95930197T patent/DK0776208T3/da active
- 1995-08-17 US US08/516,226 patent/US5658901A/en not_active Expired - Fee Related
- 1995-08-17 DE DE69513295T patent/DE69513295T2/de not_active Expired - Fee Related
- 1995-08-17 AU AU33667/95A patent/AU692300B2/en not_active Ceased
- 1995-08-17 SK SK222-97A patent/SK282019B6/sk unknown
- 1995-08-17 BR BR9508608A patent/BR9508608A/pt not_active Application Discontinuation
- 1995-08-17 JP JP8508203A patent/JPH10504570A/ja active Pending
- 1995-08-17 RU RU97104124A patent/RU2149161C1/ru active
- 1995-08-17 PL PL95319104A patent/PL319104A1/xx unknown
- 1995-08-17 ES ES95930197T patent/ES2139933T3/es not_active Expired - Lifetime
- 1995-08-17 MX MX9701195A patent/MX9701195A/es unknown
- 1995-08-17 CA CA002195974A patent/CA2195974C/en not_active Expired - Fee Related
- 1995-08-17 NZ NZ291988A patent/NZ291988A/en unknown
- 1995-08-17 WO PCT/US1995/010500 patent/WO1996005839A1/en not_active Application Discontinuation
- 1995-08-17 CZ CZ97485A patent/CZ285008B6/cs not_active IP Right Cessation
- 1995-08-17 AT AT95930197T patent/ATE186463T1/de not_active IP Right Cessation
- 1995-08-17 KR KR1019970701009A patent/KR970705395A/ko not_active Application Discontinuation
- 1995-08-17 HU HU9701275A patent/HU220635B1/hu not_active IP Right Cessation
- 1995-08-17 CN CN95195291A patent/CN1158568A/zh active Pending
-
1997
- 1997-02-12 BG BG101227A patent/BG63032B1/bg unknown
- 1997-02-17 NO NO970731A patent/NO970731D0/no not_active Application Discontinuation
- 1997-02-17 FI FI970668A patent/FI970668A0/fi unknown
-
2000
- 2000-02-04 GR GR20000400287T patent/GR3032592T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2195974A1 (en) | 1996-02-29 |
BR9508608A (pt) | 1997-12-30 |
US5658901A (en) | 1997-08-19 |
AU692300B2 (en) | 1998-06-04 |
NO970731L (no) | 1997-02-17 |
HU220635B1 (hu) | 2002-03-28 |
RU2149161C1 (ru) | 2000-05-20 |
EP0776208A1 (en) | 1997-06-04 |
DE69513295D1 (de) | 1999-12-16 |
DK0776208T3 (da) | 2000-05-01 |
DE69513295T2 (de) | 2000-06-08 |
EP0776208B1 (en) | 1999-11-10 |
BG63032B1 (bg) | 2001-02-28 |
PL319104A1 (en) | 1997-07-21 |
JPH10504570A (ja) | 1998-05-06 |
NO970731D0 (no) | 1997-02-17 |
ATE186463T1 (de) | 1999-11-15 |
HUT76811A (en) | 1997-11-28 |
CZ48597A3 (en) | 1997-09-17 |
GR3032592T3 (en) | 2000-05-31 |
SK282019B6 (sk) | 2001-10-08 |
ES2139933T3 (es) | 2000-02-16 |
MX9701195A (es) | 1997-05-31 |
WO1996005839A1 (en) | 1996-02-29 |
EP0776208A4 (en) | 1997-12-29 |
SK22297A3 (en) | 1997-09-10 |
FI970668A (fi) | 1997-02-17 |
CN1158568A (zh) | 1997-09-03 |
AU3366795A (en) | 1996-03-14 |
BG101227A (en) | 1998-03-31 |
FI970668A0 (fi) | 1997-02-17 |
CA2195974C (en) | 2000-12-05 |
CZ285008B6 (cs) | 1999-04-14 |
NZ291988A (en) | 1998-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970705395A (ko) | 2,3-디하이드로-1-(2,2,2-트리플루오로에틸)-2-옥소-5-페닐-1H-1,4-벤조디아제핀(2,3-Dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepines) | |
KR910011263A (ko) | 공포증을 치료하고 진통효과를 직접 유도하기 위한 벤조디아제핀 유사체 | |
RU97104124A (ru) | 2,3-дигидро-1-(2,2,2,-трифторэтил)-2-оксо-5-фенил-1н-1,4-бензодиазепины | |
RU94037768A (ru) | Производные 1,5-бензодиазепина, способ их получения, фармацевтическая композиция, способ лечения | |
DE69508434D1 (de) | Spiroketalderivate, diese enthaltende zusammensetzungen und ihre verwendung als arzneimittel | |
US3075967A (en) | Benzothiazines | |
KR910002817A (ko) | 항균제로서 유용한 아미노메틸옥소옥사졸리디닐 아릴벤젠 유도체 | |
ATE246190T1 (de) | Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten | |
CA2537440A1 (en) | Malonamide derivatives blocking the activity of gama-secretase | |
MA23258A1 (fr) | Nouvelle formule contenant une nouvelle forme physique d'un sel magnesium d'omeprazole, son procede de fabrication et son utilisation. | |
PE20011114A1 (es) | Decahidro-isoquinolinas | |
PT89388B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo uma piranopiridina ou um benzopirano | |
ATE435010T1 (de) | Verwendung von retinoid rezeptor antagonisten für die behandlung von knochen und knorpel pathologien | |
KR960037662A (ko) | 아릴알킬-파리다진온 유도체 | |
KR950702417A (ko) | 마이코박테륨 투베르쿨로시스에 대해 유용한 5′-인돌리닐 옥사졸리디논(5′-indolinyl oxazolidinones useful against mycobacterium tuberculosis) | |
FI964482A0 (fi) | Amidijohdannaisia ja niiden käyttö lääkkeenä | |
JP2005513049A5 (ko) | ||
KR910011807A (ko) | 4-벤질-5-페닐-2,4-디히드로-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그 의 용도 | |
AR009374A1 (es) | Compuestos novedosos antagonistas de nmda (n-metil-d-aspartato), composicion farmaceutica y usos para fabricar medicamentos. | |
RU97108129A (ru) | Нитробензамиды, применимые в качестве антиаритмических средств | |
NO305440B1 (no) | Gestagent aktive 19,11-broede 4-°strener | |
ATE13883T1 (de) | 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
ATE15802T1 (de) | 2-acylaminomethyl-1,4-benzodiazepin-verbindunge sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
KR930016417A (ko) | 피롤릴벤조디아제핀온 | |
BE896635A (fr) | Compositions pharmaceutiques analgesiques contenant des 5-phenyl-1,4-benzodiazepines. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |